Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04542486
Other study ID # PER 3-3-1
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 28, 2021
Est. completion date July 1, 2021

Study information

Verified date April 2022
Source Cairo University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Postoperative pain and wound healing are compared after using conventional scalpel technique in comparison with the intervention which is using Soft tissue Trimmer for cases of gingival hyperplasia.


Description:

In the control group: 1. Following the local anaesthetic administration, A reverse bevel gingivectomy will be performed with a #15c scalpel. 2. The borderline of gingiva will be determined via the use of a pointer dental tweezers, and excessive gingival tissue will then be removed with Gracey curettes 3. No periodontal packs to be applied to ensure accurate evaluations of follow-up pain and wound healing In the intervention group: 1. Following the local anaesthetics administration for the Soft tissue trimmer(STT) gingivectomies, Soft tissue trimmer will be used with 400-rpm rotary systems and with no serum irrigation, per the manufacturer's recommendation. 2. Gingivoplasties will be performed with the same Soft tissue trimmer to easily provide a knife-edge appearance. 3. No periodontal packs will be applied to ensure accurate evaluations of follow-up pain and wound healing.


Recruitment information / eligibility

Status Completed
Enrollment 28
Est. completion date July 1, 2021
Est. primary completion date March 1, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria: - Anterior region (minimum of four teeth at each surgical site) - Age range (18-45) years old - Plaque-induced inflammatory gingival enlargement - Altered passive eruption - No clinical attachment loss - Systemically healthy individuals Exclusion Criteria: - Gingival enlargement due to any systemic predisposing factors - Pregnancy and/or lactation - Allergy - Conditions requiring antibiotic prophylaxis and anti-inflammatory medications. - Acute or untreated periodontitis - Systemic disease that could influence the outcome of the treatment (i.e. Diabetes)

Study Design


Intervention

Procedure:
Excision of gingival hyperplasia using "Soft tissue trimmer ".
Gingivoplasties and removal of excess gingival tissues using Soft tissue trimmer.
Excision of gingival hyperplasia using the conventional scalpel technique
Excision of gingival hyperplasia in gingivoplasties using the conventional technique reverse bevel using 15c blade.

Locations

Country Name City State
Egypt Faculty of Oral and Dental Medicine-CU Cairo

Sponsors (1)

Lead Sponsor Collaborator
Cairo University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Pain VAS Visual Analogue Scale for Pain (numbers from 0 to 10 ('no pain' to 'worst pain imaginable') measured 1,3,5 and 7 days postoperatively. 7 days
Secondary Epithelization Re-epithelization after removal of excess tissue will be assessed either partial or complete.This will be tested by toluidine blue (TB) 14 days.
Secondary Tissue colour If it is either redder or whiter than the opposite side, or like opposite side tissue. 6 weeks.
Secondary Bleeding If bleeding spontaneously or on palpation exists or not. From 3-5 days
Secondary Surgical time Time taken for both groups of surgery( control and intervention) will be measured from the administration of anaesthesia till removal of excess tissues. During surgical procedure itself.
See also
  Status Clinical Trial Phase
Completed NCT05480111 - The Role of Quadratus Lumborum Blocks Following Minimally Invasive Hysterectomy Phase 4
Completed NCT06129305 - Erector Spina Muscle Distance From the Skin at Different Thoracal Elevations
Completed NCT04401826 - Micro-surgical Treatment of Gummy Smile N/A
Recruiting NCT04020133 - the Role of Popliteal Plexus Block in Pain Management After Anterior Cruciate Ligament Reconstruction. N/A
Completed NCT03023462 - Efficacy of an Anterior Quadratus Lumborum Block vs. a TAP-block for Inguinal Hernia Repair N/A
Completed NCT03546738 - Spinal Cord Burst Stimulation for Chronic Radicular Pain Following Lumbar Spine Surgery N/A
Completed NCT03652103 - Efficiency of Erector Spinae Plane Block For Patients Undergoing Percutaneous Nephrolithotomy Phase 4
Withdrawn NCT03528343 - Narcotic vs. Non-narcotic Pain Regimens After Pediatric Appendectomy Phase 1/Phase 2
Terminated NCT03261193 - ITM + Bupivacaine QLB vs. ITM + Sham Saline QLB for Cesarean Delivery Pain Phase 3
Completed NCT02525133 - Phase 3 Study of Efficacy and Safety of the XaraColl® Bupivacaine Implant After Hernioplasty Phase 3
Completed NCT03244540 - Regional Analgesia After Cesarean Section Phase 4
Enrolling by invitation NCT05316168 - Post Operative Pain Management for ACL Reconstruction Phase 3
Recruiting NCT04130464 - Intraperitoneal Infusion of Analgesic for Postoperative Pain Management Phase 4
Enrolling by invitation NCT04574791 - Addition of Muscle Relaxants in a Multimodal Analgesic Regimen for Analgesia After Primary Total Knee Arthroplasty N/A
Completed NCT04073069 - Scalp Infiltration With Diprospan Plus Ropivacaine for Postoperative Pain After Craniotomy in Adults Phase 4
Completed NCT04526236 - Influence of Aging on Perioperative Methadone Dosing Phase 4
Recruiting NCT05351229 - Intrathecal Morphine for Analgesia in Video-assisted Thoracic Surgery Phase 4
Enrolling by invitation NCT05543109 - Ultrasound Guided Psoas Compartment Block vs Suprainguinal Fascia Iliaca Compartment Block N/A
Completed NCT05346588 - THRIVE Feasibility Trial Phase 3
Completed NCT04919317 - Combination Dexamethasone and Bupivacaine Pain Control in Reduction Mammaplasty Phase 2